Published in Br J Cancer on July 28, 2009
Patient and provider preferences for survivorship care plans. J Oncol Pract (2012) 1.40
Adult cancer survivors discuss follow-up in primary care: 'not what i want, but maybe what i need'. Ann Fam Med (2012) 1.33
Views of cancer care reviews in primary care: a qualitative study. Br J Gen Pract (2011) 1.08
Increasing response rates from physicians in oncology research: a structured literature review and data from a recent physician survey. Br J Cancer (2012) 1.04
Follow-up care for cancer survivors: views of the younger adult. Br J Cancer (2009) 0.98
Are primary care providers implementing evidence-based care for breast cancer survivors? Can Fam Physician (2015) 0.93
Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer (2014) 0.89
Models of survivorship care provision in adult patients with haematological cancer: an integrative literature review. Support Care Cancer (2015) 0.87
Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma. Bone Marrow Transplant (2014) 0.79
'They're survivors physically but we want them to survive mentally as well': health care professionals' views on providing potential late effect information. Support Care Cancer (2013) 0.78
Preferences for the organization of long-term follow-up in adolescent and young adult cancer survivors. Support Care Cancer (2016) 0.77
Determining cancer survivors' preferences to inform new models of follow-up care. Br J Cancer (2016) 0.75
Primary Care Physicians' Perspectives of Their Role in Cancer Care: A Systematic Review. J Gen Intern Med (2016) 0.75
General practitioners' attitudes toward follow-up after cancer treatment: A cross-sectional questionnaire study. Scand J Prim Health Care (2015) 0.75
Chronic health conditions in adult survivors of childhood cancer. N Engl J Med (2006) 19.97
Routine follow up of breast cancer in primary care: randomised trial. BMJ (1996) 5.91
Nonmalignant late effects after allogeneic stem cell transplantation. Blood (2003) 2.95
Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev (2008) 2.48
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2005) 2.47
Early and locally advanced breast cancer: diagnosis and treatment National Institute for Health and Clinical Excellence guideline 2009. Clin Oncol (R Coll Radiol) (2009) 2.37
Questioning specialists' attitudes to breast cancer follow-up in primary care. Ann Oncol (2007) 2.19
Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ (2009) 1.95
Follow-up for people with cancer: nurse-led services and telephone interventions. J Adv Nurs (2003) 1.56
Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ (2002) 1.55
Follow-up in breast cancer clinics: reassuring for patients rather than detecting recurrence. Psychooncology (2005) 1.39
Looking beyond survival: how are we looking at survivorship? J Clin Oncol (2006) 1.38
Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer (2007) 1.17
Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. Hematology Am Soc Hematol Educ Program (2008) 1.05
Predictors of clinic satisfaction among adult survivors of childhood cancer. Eur J Cancer (2006) 1.05
Developing and piloting a nurse-led model of follow-up in the multidisciplinary management of colorectal cancer. Eur J Oncol Nurs (2006) 0.98
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet (2007) 8.08
The clinical course of bone metastases from breast cancer. Br J Cancer (1987) 4.93
The role of psychological and biological factors in postinfective gut dysfunction. Gut (1999) 4.54
A tabulated summary of the FDG PET literature. J Nucl Med (2001) 4.37
Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet (1996) 4.23
Cost effectiveness of community leg ulcer clinics: randomised controlled trial. BMJ (1998) 4.10
Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys (1997) 3.17
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
FDG PET imaging in patients with pathologically verified dementia. J Nucl Med (2000) 2.70
Randomised controlled trial of a short course of traditional acupuncture compared with usual care for persistent non-specific low back pain. BMJ (2006) 2.63
Using the SF-36 and Euroqol on an elderly population. Qual Life Res (1996) 2.53
Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford) (1999) 2.51
Structure and activity of proteins from pathogenic fungi Phytophthora eliciting necrosis and acquired resistance in tobacco. Eur J Biochem (1989) 2.49
Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice. BMJ (2002) 2.35
Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax (1997) 2.32
The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol (2004) 2.31
Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol (2000) 2.29
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol (2007) 2.24
Mental stress--induced myocardial ischemia and cardiac events. JAMA (1996) 2.20
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med (2001) 2.20
Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT. Phys Med Biol (1994) 2.19
GSP-dependent protein secretion in gram-negative bacteria: the Xcp system of Pseudomonas aeruginosa. FEMS Microbiol Rev (1998) 2.17
Exploring the anti-tumour activity of bisphosphonates in early breast cancer. Cancer Treat Rev (2008) 2.17
Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circ Res (1986) 2.15
The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel. Br J Cancer (2001) 2.14
Improved SPECT quantification using compensation for scattered photons. J Nucl Med (1984) 2.14
The skeletal metastatic complications of renal cell carcinoma. Int J Oncol (2001) 2.12
Performance characteristics of a whole-body PET scanner. J Nucl Med (1994) 2.08
Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol (1986) 2.07
Staging non-small cell lung cancer with whole-body PET. Radiology (1999) 2.07
Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy. Histopathology (2001) 2.06
Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard? Cancer Treat Rev (2004) 2.05
Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol (1991) 2.05
Acute pulmonary embolism: artificial neural network approach for diagnosis. Radiology (1993) 1.96
Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. J Lab Clin Med (1977) 1.87
Bayesian reconstruction and use of anatomical a priori information for emission tomography. IEEE Trans Med Imaging (1996) 1.87
ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett (2000) 1.81
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet (2003) 1.80
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia (2009) 1.80
Practical guidance for the management of aromatase inhibitor-associated bone loss. Ann Oncol (2008) 1.80
Dress and care of infants in health and illness. Arch Dis Child (1985) 1.78
Developing strategies for long term follow up of survivors of childhood cancer. BMJ (2001) 1.76
Pylorus-preserving pancreatoduodenectomy. A clinical and physiologic appraisal. Ann Surg (1986) 1.74
Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res (1999) 1.73
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer (2001) 1.70
Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction. FEBS Lett (1999) 1.68
In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother (1997) 1.67
Bone metastases and breast cancer. Cancer Treat Rev (1985) 1.67
Changes in understanding of illness as the child grows. Arch Dis Child (1985) 1.67
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res (2001) 1.67
Serological pattern "anti-HBc alone": report on a workshop. J Med Virol (2000) 1.65
Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol (1998) 1.64
Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet (1994) 1.64
Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis (2000) 1.63
Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol (1983) 1.62
[18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. AJNR Am J Neuroradiol (1993) 1.62
Universal prevention of depression in women postnatally: cluster randomized trial evidence in primary care. Psychol Med (2010) 1.62
Effect of age on the response of the left ventricular ejection fraction to exercise. N Engl J Med (1980) 1.61
Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease. A comparison with clinical and catheterization variables. Circulation (1990) 1.61
Cardiac phantom evaluation of simultaneously acquired dual-isotope rest thallium-201/stress technetium-99m SPECT images. J Nucl Med (1993) 1.61
Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res (1976) 1.61
Review of testing and use of adjuvant trastuzumab across a cancer network--are we treating the right patients? Clin Oncol (R Coll Radiol) (2010) 1.60
RpoS-dependent stress tolerance in Pseudomonas aeruginosa. Microbiology (1999) 1.60
Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.59
Attack context: an important mediator of the relationship between psychological status and asthma outcomes. Thorax (2002) 1.59
Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol (1998) 1.59
Issues in measuring quality of life in childhood cancer: measures, proxies, and parental mental health. J Child Psychol Psychiatry (2001) 1.59
Retrospective study of intellectual development in children treated for acute lymphoblastic leukaemia. Arch Dis Child (1977) 1.58
The effects of growth hormone treatment on health-related quality of life in children. Horm Res (2006) 1.58
Markers of bone turnover for the management of patients with bone metastases from prostate cancer. Br J Cancer (2000) 1.56
Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE). Occup Environ Med (2009) 1.56
Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology (1997) 1.56
Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. Neurology (1993) 1.54
Adult age differences in the functional neuroanatomy of verbal recognition memory. Hum Brain Mapp (1999) 1.54
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology (1993) 1.53
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring. Cancer (1995) 1.52
Human parainfluenza type 4 infection: a case report highlighting pathogenicity and difficulties in rapid diagnosis in the post-transplant setting. Bone Marrow Transplant (2002) 1.51
Cardiovascular and behavioral effects of aerobic exercise training in healthy older men and women. J Gerontol (1989) 1.51
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment. Ann Oncol (2011) 1.51
Magnesium depletion in patients receiving cisplatin-based chemotherapy. Clin Oncol (R Coll Radiol) (2006) 1.50
Cardiac troponins in serum in chronic renal failure. Clin Chem (1994) 1.49
FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med (1993) 1.47
Gallium citrate Ga 67 imaging in patients with suspected inflammatory processes. Arch Surg (1975) 1.47
Inverse Monte Carlo as a unified reconstruction algorithm for ECT. J Nucl Med (1986) 1.46
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44
A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol (1993) 1.44
Radiotherapy after ovarian transposition: ovarian function and fertility preservation. Int J Radiat Oncol Biol Phys (1993) 1.44
Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer. Eur J Cancer (2004) 1.44
An evaluation of lesion detectability with cone-beam, fanbeam and parallel-beam collimation in SPECT by continuous ROC study. J Nucl Med (1994) 1.43
The management and clinical course of testicular seminoma: 15 years' experience at a single institution. Clin Oncol (R Coll Radiol) (1998) 1.43
Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol (2001) 1.43
Ten years of rituximab in NHL. Expert Opin Drug Saf (2009) 1.42
Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg (1998) 1.42
Effects of chronic illness on intellectual development. A comparison of normal children with those treated for childhood leukaemia and solid tumours. Arch Dis Child (1980) 1.42
Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism. Radiology (1994) 1.42
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood (1999) 1.42
Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res (1998) 1.41